RELMADA THERAPEUTICS, INC. - Form 8-K Summary
Business Context and Reporting Period
RELMADA THERAPEUTICS, INC. (RLMD), a Nevada corporation, filed this Current Report on Form 8-K on August 6, 2026. The filing serves to announce a corporate update and report financial results for the three and six months ended June 30, 2026. The Company is listed on The NASDAQ Capital Market.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document states that complete unaudited condensed consolidated financial statements for the periods ended June 30, 2026, and December 31, 2025, will be contained in the Company's upcoming Quarterly Report on Form 10-Q.
Material Changes
No specific material changes in financial condition or operations are detailed within the text of this 8-K. The filing references a press release (Exhibit 99.1) and a corporate presentation (Exhibit 99.2) for detailed operational updates and financial comparisons.
Guidance, Outlook, and Management Commentary
Management announced a conference call and audio webcast scheduled for August 6, 2026, at 4:30 PM EST to discuss the corporate update and financial results. The filing includes an updated corporate presentation as Exhibit 99.2. No specific forward-looking guidance or risk factors are enumerated in the body of this report.
Investor Verification Checklist
- Review the upcoming Form 10-Q for detailed financial statements and notes.
- Access Exhibit 99.1 (Press Release) for specific financial results and operational highlights.
- Review Exhibit 99.2 (Corporate Presentation) for strategic updates and outlook.
- Listen to the conference call transcript for management commentary on the June 30, 2026 results.